Gwen Kennedy

Dr. Gwen Kennedy

University of Dundee, Dundee, Dundee City, UK
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
GKGwen Kennedy
Gwen Kennedy
VSVance A. Spence
Vance A. Spence
MMMargaret McLaren
Margaret McLaren
AHAlexander Hill
Alexander Hill
CUChristine Underwood
Christine Underwood
Jill J.F BelchJill J.F Belch
Jill J.F Belch

2 January 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
RARosa Lundbye Allesøe
Rosa Lundbye Allesøe
ALAgnete Troen Lundgaard
Agnete Troen Lundgaard
RMRicardo Hernández Medina
Ricardo Hernández Medina
AAAlejandro Aguayo-Orozco
Alejandro Aguayo-Orozco
JJJoachim Johansen
Joachim Johansen
SBSøren Brunak
Søren Brunak
The application of multiple omics technologies in biomedical cohorts has the potential to reveal patient-level disease characteristics and individualized response to treatment. However, the scale and heterogeneous nature of multi-modal data makes integration and inference a non-trivial task. We developed a deep-learning-based framework, multi-omics variational autoencoders (MOVE), to integrate such data and applied it to a cohort of 789 people with newly diagnosed type 2 diabetes with deep multi-omics phenotyping from the DIRECT consortium. Using in silico perturbations, we identified drug–omics associations across the multi-modal datasets for the 20 most prevalent drugs given to people with type 2 diabetes with substantially higher sensitivity than univariate statistical tests. From these, we among others, identified novel associations between metformin and the gut microbiota as well as opposite molecular responses for the two statins, simvastatin and atorvastatin. We used the associations to quantify drug–drug similarities, assess the degree of polypharmacy and conclude that drug effects are distributed across the multi-omics modalities.

1 July 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
FKFaisel Khan
Faisel Khan
SRSumantra Ray
Sumantra Ray
ACAngela M. Craigie
Angela M. Craigie
GKGwen Kennedy
Gwen Kennedy
AHAlexander Hill
Alexander Hill
Jill J.F BelchJill J.F Belch
Jill J.F Belch

19 June 2020 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
NANaeimeh Atabaki-Pasdar
Naeimeh Atabaki-Pasdar
MOMattias Ohlsson
Mattias Ohlsson
AVAna Viñuela
Ana Viñuela
FFFrancesca Frau
Francesca Frau
HPHugo Pomares-Millan
Hugo Pomares-Millan
PFPaul W Franks
Paul W Franks
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health complications in individuals with and without type 2 diabetes (T2D). Early diagnosis of NAFLD is important, as this can help prevent irreversible damage to the liver and, ultimately, hepatocellular carcinomas. We sought to expand etiological understanding and develop a diagnostic tool for NAFLD using machine learning. We utilized the baseline data from IMI DIRECT, a multicenter prospective cohort study of 3,029 European-ancestry adults recently diagnosed with T2D (n = 795) or at high risk of developing the disease (n = 2,234). Multi-omics (genetic, transcriptomic, proteomic, and metabolomic) and clinical (liver enzymes and other serological biomarkers, anthropometry, measures of beta-cell function, insulin sensitivity, and lifestyle) data comprised the key input variables. The models were trained on MRI-image-derived liver fat content (<5% or ≥5%) available for 1,514 participants. We applied LASSO (least absolute shrinkage and selection operator) to select features from the different layers of omics data and random forest analysis to develop the models. The prediction models included clinical and omics variables separately or in combination. A model including all omics and clinical variables yielded a cross-validated receiver operating characteristic area under the curve (ROCAUC) of 0.84 (95% CI 0.82, 0.86; p < 0.001), which compared with a ROCAUC of 0.82 (95% CI 0.81, 0.83; p < 0.001) for a model including 9 clinically accessible variables. The IMI DIRECT prediction models outperformed existing noninvasive NAFLD prediction tools. One limitation is that these analyses were performed in adults of European ancestry residing in northern Europe, and it is unknown how well these findings will translate to people of other ancestries and exposed to environmental risk factors that differ from those of the present cohort. Another key limitation of this study is that the prediction was done on a binary outcome of liver fat quantity (<5% or ≥5%) rather than a continuous one. In this study, we developed several models with different combinations of clinical and omics data and identified biological features that appear to be associated with liver fat accumulation. In general, the clinical variables showed better prediction ability than the complex omics variables. However, the combination of omics and clinical variables yielded the highest accuracy. We have incorporated the developed clinical models into a web interface (see: https://www.predictliverfat.org/) and made it available to the community. ClinicalTrials.gov NCT03814915.

4 January 2022 in Cell Reports Medicine
Verified
Journal Article
Open access
AWAgata Wesolowska-Andersen
Agata Wesolowska-Andersen
CBCaroline A. Brorsson
Caroline A. Brorsson
RBRoberto Bizzotto
Roberto Bizzotto
AMAndrea Mari
Andrea Mari
ATAndrea Tura
Andrea Tura
SBSøren Brunak
Søren Brunak
The presentation and underlying pathophysiology of type 2 diabetes (T2D) is complex and heterogeneous. Recent studies attempted to stratify T2D into distinct subgroups using data-driven approaches, but their clinical utility may be limited if categorical representations of complex phenotypes are suboptimal.

1 November 1999 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
TETarik A. Elhadd
Tarik A. Elhadd
GKGwen Kennedy
Gwen Kennedy
AHAlexander Hill
Alexander Hill
MMMargaret McLaren
Margaret McLaren
RNRay W. Newton
Ray W. Newton
Jill J.F BelchJill J.F Belch
Jill J.F Belch
Background Endothelial cell dysfunction is an early feature of vascular disease and oxidative stress may be involved in its pathogenesis. Methods Fifty‐one children, adolescents and young people with Type 1 diabetes with no clinical diabetic angiopathy, mean age±SD of 16±4 years, diabetes duration of 8±5 years, and HbA1c of 8.5±1.6%, and 29 age, sex matched normal controls had blood samples assayed for E‐selectin, intercellular cell adhesion molecule‐1, von Willebrand Factor, red cell superoxide dismutase, plasma thiol and red cell glutathione. Results E‐selectin and ICAM‐1 levels were significantly higher in the diabetic patients at 72±24 ng/ml and 287±57 ng/ml, respectively vs 43±16 ng/ml and 248±71 ng/ml in the normal controls (p<0.0002 and p<0.013). Von Willebrand Factor levels were not different between the two groups. Superoxide dismutase activity was significantly higher in the diabetic group at 220±58 µ/ml vs 175±24 µ/ml in the normal controls p<0.001, and those of plasma thiol and red cell glutathione were significantly lower in the diabetic group, at 1267±202 µmol/l and 458±38 µmol/l, respectively vs 1403±278 µmol/l and 487±70 µmol/l in the controls p<0.02 and p<0.03. Levels of superoxide dismutase correlated negatively with plasma thiol, age and diabetes duration r=−0.318, p<0.02; r=−0.328, p<0.02; and r=−0.286, p<0.05, respectively. Conclusion These results confirm evidence of endothelial perturbation in young people with diabetes mellitus, and they also suggest that free radical generation may contribute to this dysfunction. This supports the hypothesis that vascular disease starts early in the course of childhood diabetes, akin to the situation in adults with diabetes. Copyright © 1999 John Wiley & Sons, Ltd.